Point-of-care quantitative measure of glucose-6-phosphate dehydrogenase enzyme deficiency

Pediatrics

Volumn 136, Issue 5, 2015, Pages e1268-e1275

  Bhutani, Vinod K ^a,f   Kaplan, Michael ^b   Glader, Bertil ^a   Cotten, Michael ^c   Kleinert, Jairus ^d   Pamula, Vamsee ^e  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Advanced Liquid Logic Inc   (United States)

^e Baebies   (United States)

^f STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE;

ADULT; ANALYZER; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIGITAL MICROFLUIDIC ANALYZER; ENZYME ACTIVITY; EQUIPMENT DESIGN; FEMALE; FLUORESCENCE ANALYSIS; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; MICROFLUIDIC ANALYSIS; NEWBORN; NEWBORN SCREENING; POINT OF CARE TESTING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; CHILD; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; INFANT;

ADULT; CHILD; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; INFANT; INFANT, NEWBORN; MALE; POINT-OF-CARE TESTING;

EID: 84947218636     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2015-2122     Document Type: Article

References (24)

1. Keren R, Luan X, Friedman S, Saddlemire S, Cnaan A, Bhutani VK. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics. 2008;121(1). Available at: www.pediatrics.org/cgi/content/full/121/1/e170
2. Bhutani VK, Stark AR, Lazzeroni LC, et al; Initial Clinical Testing Evaluation and Risk Assessment for Universal Screening for Hyperbilirubinemia Study Group. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr. 2013;162(3): 477-482.e1
3. Hameed NN, Na' Ma AM, Vilms R, Bhutani VK. Severe neonatal hyperbilirubinemia and adverse short-term consequences in Baghdad, Iraq. Neonatology. 2011;100(1): 57-63
4. Olusanya BO, Emokpae AA, Zamora TG, Slusher TM. Addressing the burden of neonatal hyperbilirubinaemia in countries with significant glucose-6-phosphate dehydrogenase deficiency. Acta Paediatr. 2014;103(11):1102-1109
5. Gamaleldin R, Iskander I, Seoud I, et al. Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia. Pediatrics. 2011; 128(4). Available at: www.pediatrics.org/cgi/content/full/128/4/e925
6. Bhutani VK, Zipursky A, Blencowe H, et al. Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res. 2013;74(suppl 1):86-100
7. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol. 2009;29(suppl 1): S25-S45
8. Kuzniewicz MW, Wickremasinghe AC, Wu YW, et al. Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns. Pediatrics. 2014;134(3):504-509
9. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ. 2006;175(6):587-590
10. Manning D, Todd P, Maxwell M, Jane Platt M. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed. 2007;92(5): F342-F346
11. Millington DS, Sista R, Eckhardt A, et al. Digital microfluidics: a future technology in the newborn screening laboratory? Semin Perinatol. 2010;34(2): 163-169
12. Beutler E. Red Cell Metabolism: A Manual of Biochemical Methods. 3rd ed. Orlando, FL: Grune & Stratton; 1984
13. Sista RS, Eckhardt AE, Wang T, et al. Digital microfluidic platform for multiplexing enzyme assays: implications for lysosomal storage disease screening in newborns. Clin Chem. 2011;57(10): 1444-1451
14. WHO Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ. 1989;67(6): 601-611
15. Luzzatto L. Glucose 6-phosphate dehydrogenase deficiency: from genotype to phenotype. Haematologica. 2006;91(10):1303-1306
16. Kaplan M, Hammerman C, Bhutani VK. Parental education and the WHO neonatal G-6-PD screening program: a quarter century later [published online ahead of print July 16, 2015]. J Perinatol. doi: 10.1038/jp.2015.77
17. Watchko JF, Kaplan M, Stark AR, Stevenson DK, Bhutani VK. Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States? J Perinatol. 2013; 33(7):499-504
18. Kaplan M, Hoyer JD, Herschel M, Hammerman C, Stevenson DK. Glucose-6-phosphate dehydrogenase activity in term and near-term, male African American neonates. Clin Chim Acta. 2005; 355(1-2):113-117
19. Kaplan M, Herschel M, Hammerman C, Hoyer JD, Stevenson DK. Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics. 2004;114(2). Available at: www.pediatrics.org/cgi/content/full/114/2/e213
20. Algur N, Avraham I, Hammerman C, Kaplan M. Quantitative neonatal glucose-6-phosphate dehydrogenase screening: distribution, reference values, and classification by phenotype. J Pediatr. 2012; 161(2):197-200
21. Sista R, Hua Z, Thwar P, et al. Development of a digital microfluidic platform for point of care testing. Lab Chip. 2008;8(12):2091-2104
22. Kaplan M, Renbaum P, Levy-Lahad E, Hammerman C, Lahad A, Beutler E. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci USA. 1997;94(22): 12128-12132
23. Sista RS, Wang T, Wu N, et al. Multiplex newborn screening for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases using a digital microfluidic platform. Clin Chim Acta. 2013;424:12-18
24. Hopkins PV, Campbell C, Klug T, Rogers S, Raburn-Miller J, Kiesling J. Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri. J Pediatr. 2015; 166(1):172-177